These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34408079)

  • 1. ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156.
    Koneru B; Farooqi A; Nguyen TH; Chen WH; Hindle A; Eslinger C; Makena MR; Burrow TA; Wilson J; Smith A; Pilla Reddy V; Cadogan E; Durant ST; Reynolds CP
    Sci Transl Med; 2021 Aug; 13(607):. PubMed ID: 34408079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function.
    Macha SJ; Koneru B; Burrow TA; Zhu C; Savitski D; Rahman RL; Ronaghan CA; Nance J; McCoy K; Eslinger C; Reynolds CP
    Cancer Res; 2022 Sep; 82(18):3345-3358. PubMed ID: 35947641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
    Jones GN; Rooney C; Griffin N; Roudier M; Young LA; Garcia-Trinidad A; Hughes GD; Whiteaker JR; Wilson Z; Odedra R; Zhao L; Ivey RG; Howat WJ; Harrington EA; Barrett JC; Ramos-Montoya A; Lau A; Paulovich AG; Cadogan EB; Pierce AJ
    Br J Cancer; 2018 Nov; 119(10):1233-1243. PubMed ID: 30385821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
    George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
    J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
    Riches LC; Trinidad AG; Hughes G; Jones GN; Hughes AM; Thomason AG; Gavine P; Cui A; Ling S; Stott J; Clark R; Peel S; Gill P; Goodwin LM; Smith A; Pike KG; Barlaam B; Pass M; O'Connor MJ; Smith G; Cadogan EB
    Mol Cancer Ther; 2020 Jan; 19(1):13-25. PubMed ID: 31534013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
    Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
    Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.
    Davis SL; Hartman SJ; Bagby SM; Schlaepfer M; Yacob BW; Tse T; Simmons DM; Diamond JR; Lieu CH; Leal AD; Cadogan EB; Hughes GD; Durant ST; Messersmith WA; Pitts TM
    BMC Cancer; 2022 Oct; 22(1):1107. PubMed ID: 36309653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
    Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J
    Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Akter J; Kamijo T
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres.
    Tong AS; Stern JL; Sfeir A; Kartawinata M; de Lange T; Zhu XD; Bryan TM
    Cell Rep; 2015 Nov; 13(8):1633-46. PubMed ID: 26586433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
    Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
    Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
    Goncalves T; Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Collopy LC; Strauss SJ; Mittnacht S; Tomita K
    ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1253-1264. PubMed ID: 33344901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres.
    Feldser D; Strong MA; Greider CW
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2249-51. PubMed ID: 16467146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.
    Stohr BA; Blackburn EH
    Cancer Res; 2008 Jul; 68(13):5309-17. PubMed ID: 18593932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR suppresses telomere fragility and recombination but is dispensable for elongation of short telomeres by telomerase.
    McNees CJ; Tejera AM; Martínez P; Murga M; Mulero F; Fernandez-Capetillo O; Blasco MA
    J Cell Biol; 2010 Mar; 188(5):639-52. PubMed ID: 20212315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal telomere maintenance in immortal ataxia telangiectasia cell lines.
    Sprung CN; Bryan TM; Reddel RR; Murnane JP
    Mutat Res; 1997 Oct; 379(2):177-84. PubMed ID: 9357546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
    Hu J; Hwang SS; Liesa M; Gan B; Sahin E; Jaskelioff M; Ding Z; Ying H; Boutin AT; Zhang H; Johnson S; Ivanova E; Kost-Alimova M; Protopopov A; Wang YA; Shirihai OS; Chin L; DePinho RA
    Cell; 2012 Feb; 148(4):651-63. PubMed ID: 22341440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arabidopsis ATM and ATR kinases prevent propagation of genome damage caused by telomere dysfunction.
    Amiard S; Depeiges A; Allain E; White CI; Gallego ME
    Plant Cell; 2011 Dec; 23(12):4254-65. PubMed ID: 22158468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.